IN8BIO, Inc.
INABNasdaqCIK 1740279HealthcareFiscal year ends Dec 31
Reports and events: 118 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:11 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338012 |
| 2026-08-0616:05 ET | 8-K | 2.02 Results of operations | 0001193125-26-337944 |
| 2026-06-0106:56 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-249684 |
| 2026-05-2917:41 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001682638-26-000008 |
| 2026-05-0716:32 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212135 |
| 2026-05-0716:31 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-212128 |
| 2026-03-2616:05 ET | DEF 14A | Proxy statementPeriod 2026-05-07 | 0001193125-26-126208 |
| 2026-03-1216:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-104181 |
| 2026-03-1216:10 ET | 8-K | 2.02 Results of operations | 0001193125-26-104144 |
| 2026-02-2716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-082539 |
| 2026-02-0908:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-041975 |
| 2026-01-0219:10 ET | SCHEDULE 13D | Ownership report, active investor | 0001682638-26-000002 |
| 2025-12-2916:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001714576-25-000003 |
| 2025-12-1917:22 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-327097 |
| 2025-11-2408:00 ET | 8-K | 8.01 Other events | 0001193125-25-292057 |
| 2025-11-0616:03 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269447 |
| 2025-11-0616:01 ET | 8-K | 2.02 Results of operations | 0001193125-25-269442 |
| 2025-10-2708:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-250756 |
| 2025-08-0716:11 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105028 |
| 2025-08-0716:06 ET | 8-K | 2.02 Results of operations | 0000950170-25-104986 |
| 2025-06-3008:30 ET | 8-K | 8.01 Other events | 0001193125-25-152037 |
| 2025-06-0408:00 ET | 8-K | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-134487 |
| 2025-06-0207:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-132783 |
| 2025-05-0916:15 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-116901 |
| 2025-05-0817:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-046280 |
| 2025-05-0716:21 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001193125-25-114915 |
| 2025-05-0716:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-065609 |
| 2025-05-0716:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065603 |
| 2025-04-2808:56 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-098599 |
| 2025-04-2808:56 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-098597 |
| 2025-03-1716:05 ET | DEF 14A | Proxy statementPeriod 2025-05-08 | 0001193125-25-055610 |
| 2025-03-1316:10 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-038738 |
| 2025-03-1316:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-038728 |
| 2025-03-0516:35 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-047244 |
| 2025-03-0309:29 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-043564 |
| 2025-02-1108:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-024005 |
| 2025-02-0716:02 ET | 8-K | 3.01 Delisting notice; 5.08 Item not in the standard list | 0001193125-25-022711 |
| 2024-12-1007:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-273953 |
| 2024-11-2507:09 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-264714 |
| 2024-11-1216:33 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125537 |
| 2024-11-1216:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125526 |
| 2024-10-1118:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-108134 |
| 2024-10-0116:59 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-24-230283 |
| 2024-09-1116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-217229 |
| 2024-09-0616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-215154 |
| 2024-09-0416:18 ET | 8-K | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-213132 |
| 2024-08-1208:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-198411 |
| 2024-08-0816:10 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093943 |
| 2024-08-0816:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093932 |
| 2024-06-1316:07 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-160703 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.